GI fellow at UMass Chan Medical School - Baystate | @UMassChan @BaystateGI | Alumnus @AKUGlobal. Interested in all things GI and advanced endoscopy
United States (National)
Not enough data
Syed's coverage predominantly focuses on the healthcare and pharmaceutical industry, with a notable emphasis on technological advancements and private sector announcements. Given this focus, he may be responsive to pitches offering insights into innovations in medical technology, AI applications in healthcare, or partnerships within the industry.
Considering his high percentage of press releases and private sector announcements, it's likely that Syed would prioritize news directly from companies or organizations rather than expert commentary. However, if you have data-driven insights related to healthcare technology trends or can provide context for recent developments in the industry, your pitch might resonate with him.
While there is no specified geographic focus for Syed’s articles based on his coverage attributes and topics covered, he seems to cover international developments within the healthcare and pharmaceutical sectors without a specific regional limitation.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Syed Hamza Sohail
Infinitus Systems, Inc., healthcare’s leading agentic communications partner powering more than 100 million minutes of conversations, today launched its next generation of clinical AI agents for patient-facing conversations.
By: Syed Hamza Sohail
Ritten, a leading AI-powered system of record for behavioral health providers, today announced a $35 million USD Series B funding round led by Five Elms Capital with participation from existing investors Threshold Ventures, 8VC, Bienville Capital, and others.
By: Syed Hamza Sohail
Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly outperformed manual screening for determining a patient’s eligibility and enrolling them in a clinical trial.
By: Syed Hamza Sohail
Hundred Health today announced the launch of its integrated health platform and mobile app, ushering in a new era of proactive and personalized health management.
By: Syed Hamza Sohail
Valerie Health, the AI front office for independent provider groups, today announced a $30 million Series A led by Redpoint Ventures, bringing total funding to $39 million.
By: Syed Hamza Sohail
PeopleOne Health, a leader in value-based primary care, today announced a strategic partnership with the Orlando Regional REALTOR® Association (ORRA), one of the most innovative local real estate associations in the country, to bring affordable concierge-level healthcare directly to Central Florida’s real estate professionals.
By: Syed Hamza Sohail
Teal Health, a virtual women’s health company on a mission to eliminate cervical cancer in the U.S., today announced the national availability of its comprehensive telehealth platform and its FDA-authorized self-collection device for at-home cervical cancer screening, the Teal Wand™. Cervical cancer screening, often referred to as the pap smear, is a recommended screening for all women ages 25-65.
By: Syed Hamza Sohail
Oasys Health (“Oasys”), the first AI-native operating system for behavioral health, today announces $4.6M in funding, including a $4M seed round led by Pathlight Ventures, with participation from Twine Ventures and Better Ventures, and $600K in pre-seed funding from 1984 Ventures.
By: Syed Hamza Sohail
Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has announced the merger with COTA Healthcare®.
By: Syed Hamza Sohail
The Funding: Health Universe raised $6M in seed funding led by Kleiner Perkins, bringing total funding to $9.5M following a 2023 pre-seed backed by Susa Ventures, Twelve Below, and Oncology Ventures. The Core Problem: Healthcare systems face escalating administrative burden, clinician burnout, and prolonged clinical trial timelines, while existing AI tools lack transparency, auditability, and regulatory readiness.
